EN
HI
CORONA Remedies share price chart
CORONA Remedies Share Key Metrics
Volume
13409.00
Market Cap
12493.78 CR
LTQ@LTP
9@2042.80
ATP
2048.14
Var Margin
13.19 %
Circuit Range
1634.3-2451.3
Delivery %
42.47 %
Value
2.75 CR
ASM/GSM
No
Market Lot
1
Summary
CORONA stock price is ₹2042.8 as of 12 Jul, 2026. The stock intraday movement has stayed between ₹2022.80 and ₹2070.90, while CORONA Remedies share price 52 week high low is ₹1336.60 & ₹2100.70.
In terms of trading activity, CORONA share price has recorded a volume of 13,409 shares. The CORONA Remedies has a market cap of ₹61160088. The stock’s Average Traded Price (ATP) stands at ₹2048.14, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹2042.80.
The CORONA Remedies upper circuit limit is ₹2451.30 & The CORONA Remedies lower circuit limit is ₹1634.30, with a Value of ₹2.75 CR. The Delivery Percentage for the day is 42.47%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
CORONA Remedies Fundamentals
P/E Ratio
67.29
P/B Ratio
16.68
Div. Yield
0.49
Sector P/E
69.77
Sector P/B
3.23
Sec. Div. Yield
0.53
CORONA Remedies Resistance and Support
Pivot 2017.93
Resistance
First Resistance
2050.96
Second Resistance
2079.13
Third Resistance
2112.16
Support
First Support
1989.76
Second Support
1956.73
Third Support
1928.56
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Commencement Of Commercial Production
Corona Remedies Limited has inaugurated and commenced commercial production at its new EU-GMP approved Women's Hormone manufacturing facility in Bhayla, Ahmedabad. This facility is expected to increase the company's in-house hormone manufacturing capacity by nearly 20%.
Jun 30 2026 16:34:20
Corona Remedies Ltd - 544644 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sepia Investments, Anchor Partners, and Sage Investment Trust (collectively as PACs) sold a total of 7.49% stake in Corona Remedies through open market transactions on June 17, 2026. This significant stake reduction by substantial shareholders can be perceived negatively by the market.
Jun 19 2026 13:09:50
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Rainbow Children's Medicare Ltd.
1470.40
-11.10 (0.75%)
Vijaya Diagnostic Centre Ltd.
1389.10
11.30 (0.82%)
Concord Biotech Ltd.
1304.70
-0.70 (0.05%)
Alivus Life Sciences Ltd.
1160.10
17.20 (1.50%)
Marksans Pharma Ltd.
272.40
-4.90 (1.77%)
Viyash Scientific Ltd.
277.80
-3.25 (1.16%)
Park Medi World Ltd.
286.10
-4.05 (1.40%)
Shilpa Medicare Ltd.
627.15
4.85 (0.78%)
Metropolis Healthcare Ltd.
567.95
7.90 (1.41%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 2042.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 67.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 16.68. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 69.77 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 12493.78 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2100.70 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
